A522 Clinical Efficacy of Velcade/CTD Regimen in Patients with Relapsed or Refractory Multiple Myeloma

Autor: SK Sohn, YK Kim, YS Chae, JS Chung, JH Moon, HJ Shin, YD Joo, JS Ahn, JJ Lee, DH Yang, HJ Kim

Publikováno v: Clinical Lymphoma and Myeloma. 9:S81

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fbf3474f59e3359ff081966bfa3c5121
https://doi.org/10.1016/s1557-9190(11)70611-4

Effect of activated carbon-based two-stage adsorption on biogenic amine reduction and quality of anchovy fish sauce at industrial scale.

Autor: In JJ; Department of Food Science and Technology, Pukyong National University, Busan 48513, Republic of Korea., Shim KB; Department of Food Science and Technology, Pukyong National University, Busan 48513, Republic of Korea. Electronic address: kbshim@pknu.ac.kr., Lee JB; Department of Food Science and Technology, Pukyong National University, Busan 48513, Republic of Korea., Bae YJ; Department of Food Science and Technology, Pukyong National University, Busan 48513, Republic of Korea., Kwon GY; Department of Food Science and Technology, Pukyong National University, Busan 48513, Republic of Korea., Lee HR; Department of Food Science and Technology, Pukyong National University, Busan 48513, Republic of Korea., Park S; Food Standard Research Center, Korea Food Research Institute, Jeollabuk-do 55365, Republic of Korea., Sohn SK; Department of Food Science and Technology, Pukyong National University, Busan 48513, Republic of Korea.

Publikováno v: Food chemistry [Food Chem] 2024 Nov 15; Vol. 458, pp. 140169. Date of Electronic Publication: 2024 Jun 21.

Synergistic Effect of Venetoclax and Bendamustine in Early T-cell Precursor Acute Lymphoblastic Leukemia.

Autor: Nguyen HDT; Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.; BK21 Four Program, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., LE TM; Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.; BK21 Four Program, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Lee D; Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.; BK21 Four Program, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Cho HJ; Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Lee J; Department of Hematology/Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Sohn SK; Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Kim JG; Department of Hematology/Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Ham JY; Department of Laboratory Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Moon JH; Department of Hematology/Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Han HS; Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu, Republic of Korea.; BK21 Four Program, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Kim J; Department of Hematology/Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea; dnakim1@gmail.com., Baek DW; Department of Hematology/Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea; baekdw83@gmail.com.

Publikováno v: In vivo (Athens, Greece) [In Vivo] 2024 Jul-Aug; Vol. 38 (4), pp. 1740-1749.

Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia.

Autor: Song GY; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Jeollanam-Do, Republic of Korea., Kim HJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Jeollanam-Do, Republic of Korea., Kim T; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.; Department of Computer Science, University of Toronto, Toronto, ON, Canada.; The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada., Ahn SY; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Jeollanam-Do, Republic of Korea., Jung SH; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Jeollanam-Do, Republic of Korea., Kim M; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Jeollanam-Do, Republic of Korea., Yang DH; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Jeollanam-Do, Republic of Korea., Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Jeollanam-Do, Republic of Korea., Kim MY; Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Gwangju, Jeollanam-Do, Republic of Korea., Cheong JW; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea., Jung CW; Division of Hematology-Oncology, Samsung Medical Center, Seoul, South Korea., Jang JH; Division of Hematology-Oncology, Samsung Medical Center, Seoul, South Korea., Kim HJ; Department of Hematology, The Catholic University of Korea, Seoul, South Korea., Moon JH; Department of Hematology-Oncology, School of Medicine, Kyungpook National University Hospital, Kyungpook National University, Daegu, South Korea., Sohn SK; Department of Hematology-Oncology, School of Medicine, Kyungpook National University Hospital, Kyungpook National University, Daegu, South Korea., Won JH; Division of Hematology & Oncology, Department of Internal Medicine, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, South Korea., Park SK; Division of Hematology & Oncology, Department of Internal Medicine, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, South Korea., Kim SH; Department of Hematology-Oncology, Dong-A University College of Medicine, Busan, South Korea., Choi CK; Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Canter, Goyang, South Korea., Kim HJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Jeollanam-Do, Republic of Korea.; Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Gwangju, Jeollanam-Do, Republic of Korea., Ahn JS; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Jeollanam-Do, Republic of Korea. f0115@chonnam.ac.kr.; Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Gwangju, Jeollanam-Do, Republic of Korea. f0115@chonnam.ac.kr.; Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University, 322 Seoyang-Ro, Hwasun-Eup, Hwasun-Gun, Jeollanam-Do, 58128, Republic of Korea. f0115@chonnam.ac.kr., Kim DDH; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. dr.dennis.kim@uhn.ca.

Publikováno v: Scientific reports [Sci Rep] 2024 Apr 12; Vol. 14 (1), pp. 8517. Date of Electronic Publication: 2024 Apr 12.

Effect of BCR::ABL1 transcript type and droplet digital polymerase chain reaction on successful treatment-free remission in chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitor.

Autor: Park H; Department of Internal Medicine, Seoul National University-Seoul Metropolitan Government Boramae Medical Center, Seoul, South Korea., Kim HJ; Department of Internal Medicine, Chonnam National University, Hwasun Hospital, Hwasun, South Korea., Sohn SK; Department of Internal Medicine, Kyungpook National University Hospital, Daegu, South Korea., Baik Y; LAS Inc., Gimpo, South Korea., Kim D; LAS Inc., Gimpo, South Korea., Lee SY; LAS Inc., Gimpo, South Korea., Kong JH; Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, South Korea., Kim H; Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea., Shin DY; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea., Ahn JS; Department of Internal Medicine, Chonnam National University, Hwasun Hospital, Hwasun, South Korea., Park J; Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea., Park S; Department of Internal Medicine, Inje University, Haeundae Paik Hospital, Busan, South Korea., Kim I; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 101, Daehak-ro, Jongno-gu, Seoul 03080, South Korea.

Publikováno v: Therapeutic advances in hematology [Ther Adv Hematol] 2023 Nov 02; Vol. 14, pp. 20406207231205637. Date of Electronic Publication: 2023 Nov 02 (Print Publication: 2023).